No role for early IGF-1 signalling in stimulating acute 'muscle building' responses

J Physiol. 2011 Jun 1;589(Pt 11):2667-8. doi: 10.1113/jphysiol.2011.207332.
No abstract available

Publication types

  • Comment

MeSH terms

  • Androstadienes / pharmacology
  • Animals
  • Hypertrophy / metabolism*
  • Insulin-Like Growth Factor I / physiology*
  • MAP Kinase Signaling System / physiology
  • Mechanistic Target of Rapamycin Complex 1
  • Mice
  • Multiprotein Complexes
  • Muscle Proteins / biosynthesis
  • Muscle, Skeletal / metabolism*
  • Muscle, Skeletal / pathology
  • Organ Size / physiology
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation / drug effects
  • Phosphorylation / physiology
  • Proteins / antagonists & inhibitors
  • Proteins / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction / physiology*
  • Sirolimus / pharmacology
  • TOR Serine-Threonine Kinases
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Proteins / metabolism
  • Weight-Bearing / physiology*
  • Wortmannin

Substances

  • Androstadienes
  • Multiprotein Complexes
  • Muscle Proteins
  • Phosphoinositide-3 Kinase Inhibitors
  • Proteins
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Proteins
  • insulin-like growth factor-1, mouse
  • Insulin-Like Growth Factor I
  • Mechanistic Target of Rapamycin Complex 1
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • Sirolimus
  • Wortmannin